Internal Medicine, Hematology & Oncology · Scottsdale, AZ
NPI
1790793271
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
13400 E Shea Blvd
Scottsdale, AZ, 85259
Phone (480) 301-8000
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
48,189 services
Medicare patients, 2024
479
Average age 74
Drug cost, 2024
$3.2M
555 prescriptions
Company payments, 2025
$0
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jose F Leis was code J9271 (injection, pembrolizumab, 1 mg), 6,000 times for 23 patients. In total Jose F Leis billed 48,189 services in 129 codes, and Medicare paid $1.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 6,000 | 23 | $44.45 | $267K |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 5,400 | 27 | $39.48 | $213K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 4,200 | 25 | $0.11 | $479 |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 940 | 17 | $34.82 | $33K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 536 | 48 | $0.09 | $48.56 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 370 | 34 | $0.86 | $317 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 304 | 30 | $0.07 | $22.61 |
| 99214 Office E&M - Established | Office | 263 | 158 | $83.89 | $22K |
| 96375 Injection Administration | Office | 186 | 74 | $11.78 | $2,190 |
| J9045 Injection, carboplatin, 50 mg | Office | 150 | 14 | $2.89 | $434 |
| 96413 Chemotherapy Administration | Office | 123 | 107 | $98.23 | $12K |
| 99233 Hospital E&M - Subsequent | Facility | 76 | 27 | $89.72 | $6,819 |
| 36591 Vascular | Office | 62 | 56 | $20.55 | $1,274 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 62 | 14 | $140.19 | $8,692 |
| 99215 Office E&M - Established | Office | 60 | 40 | $125.21 | $7,512 |
By year: 2022 $2.6M for 138,048 services; 2023 $1.4M for 73,994 services; 2024 $1.3M for 48,189 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jose F Leis prescribed most often to Medicare patients was Acyclovir, with 111 prescriptions and refills. In total Jose F Leis wrote 555 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 111 | 206 | 36 | $2,197 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 61 | 76 | 16 | $249 |
| Imbruvica Ibrutinib | 54 | 54 | Under 11 | $861K |
| Brukinsa Zanubrutinib | 37 | 37 | Under 11 | $454K |
| Venclexta Venetoclax | 36 | 36 | Under 11 | $348K |
| Allopurinol Generic | 30 | 37 | 15 | $147 |
| Jaypirca Pirtobrutinib | 29 | 29 | Under 11 | $660K |
| Jakafi Ruxolitinib Phosphate | 17 | 17 | Under 11 | $287K |
| Prochlorperazine Maleate Generic | 16 | 16 | 11 | $158 |
| Imatinib Mesylate Generic | 12 | 12 | Under 11 | $3,328 |
| Azithromycin Generic | 11 | 11 | Under 11 | $42.64 |
| Gleevec Imatinib Mesylate | 11 | 11 | Under 11 | $114K |
| Calquence Acalabrutinib Maleate | 11 | 11 | Under 11 | $171K |
Brand drugs: - claims; generic drugs: 320 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jose F Leis $0 (- in general payments such as food, travel and fees) from 1 company.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.